PMOS (Formerly PCOS) Linked to ‘Significantly Higher’ Heart Attack, Stroke Risk

# PMOS Linked to Significantly Higher Heart Attack and Stroke Risk

Women with PMOS, formerly known as PCOS (polycystic ovary syndrome), face substantially elevated risks for heart attack and stroke, according to new research. The condition affects an estimated 8-20% of women of reproductive age.

PMOS is an endocrine disorder characterized by irregular periods, elevated androgen levels, and ovarian cysts. The metabolic disruptions it causes extend far beyond reproductive health. Women with PMOS develop insulin resistance at higher rates than the general population, and this metabolic dysfunction appears central to cardiovascular complications.

Recent cardiovascular studies document the scope of the problem. Women with PMOS show increased arterial stiffness, elevated blood pressure, and unfavorable cholesterol profiles. These factors combine to create a compounding risk for serious cardiac events.

The cardiovascular threat emerges even in younger women with PMOS, challenging the perception that heart disease primarily affects older populations. Hormonal imbalances characteristic of the condition promote inflammation and endothelial dysfunction, mechanisms that accelerate atherosclerosis development.

Cardiologists and reproductive endocrinologists increasingly recommend that women with PMOS receive cardiovascular screening as part of routine care. This includes blood pressure monitoring, lipid panels, and glucose tolerance assessments. Lifestyle interventions prove particularly effective. Regular physical activity, weight management, and dietary changes targeting insulin sensitivity reduce both PMOS symptoms and cardiovascular risk.

Medications like metformin, commonly used to treat insulin resistance in PMOS, also offer heart-protective effects. Women with PMOS should work with their healthcare providers to establish personalized prevention strategies rather than waiting for symptoms to develop.

The renaming from PCOS to PMOS reflects growing recognition that the condition affects multiple body systems, not just the ovaries.